Characterization of the In Vitro and In Vivo Efficacy of Baloxavir Marboxil against H5 Highly Pathogenic Avian Influenza Virus Infection
Authors:
- Keiichi TaniguchiKTKeiichi Taniguchi
- Yoshinori AndoYAYoshinori Ando
- Masanori KobayashiMKMasanori Kobayashi
- Shinsuke TobaSTShinsuke Toba
- Haruaki NoboriHNHaruaki Nobori
- Takao SanakiTSTakao Sanaki
- Takeshi NoshiTNTakeshi Noshi
- Makoto KawaiMKMakoto Kawai
- Ryu YoshidaRYRyu Yoshida
- Akihiko SatoASAkihiko Sato
- Takao ShishidoTSTakao Shishido
- Akira NaitoANAkira Naito
Open Access
Abstract
Human infections caused by the H5 highly pathogenic avian influenza virus (HPAIV) sporadically threaten public health. The susceptibility of HPAIVs to baloxavir acid (BXA), a new class of inhibitors for the influenza virus cap-dependent endonuclease, has been confirmed in vitro, but it has not yet been fully characterized. Here, the efficacy of BXA against HPAIVs, including recent H5N8 variants, was assessed in vitro. The antiviral efficacy of baloxavir marboxil (BXM) in H5N1 virus-infected mice was also investigated. BXA exhibited similar in vitro activities against H5N1, H5N6, and H5N8 variants tested in comparison with seasonal and other zoonotic strains. Compared with oseltamivir phosphate (OSP), BXM monotherapy in mice infected with the H5N1 HPAIV clinical isolate, the A/Hong Kong/483/1997 strain, also caused a significant reduction in viral titers in the lungs, brains, and kidneys, thereby preventing acute lung inflammation and reducing mortality. Furthermore, compared with BXM or OSP monotherapy, combination treatments with BXM and OSP using a 48-h delayed treatment model showed a more potent effect on viral replication in the organs, accompanied by improved survival. In conclusion, BXM has a potent antiviral efficacy against H5 HPAIV infections.Keywords
All Related Versions
This publication has 66 references indexed in Scilit:
- Neurovirulence of H5N1 Infection in Ferrets Is Mediated by Multifocal Replication in Distinct Permissive Neuronal Cell RegionsPLOS ONE, 2012
- The Virulence of 1997 H5N1 Influenza Viruses in the Mouse Model Is Increased by Correcting a Defect in Their NS1 ProteinsJournal of Virology, 2011
- Effects of the Combination of Favipiravir (T-705) and Oseltamivir on Influenza A Virus Infections in MiceAntimicrobial Agents and Chemotherapy, 2010
- T-705 (favipiravir) activity against lethal H5N1 influenza A virusesProceedings of the National Academy of Sciences, 2009
- Pulmonary fibrosis induced by H5N1 viral infection in miceRespiratory Research, 2009
- H5N1 and 1918 Pandemic Influenza Virus Infection Results in Early and Excessive Infiltration of Macrophages and Neutrophils in the Lungs of MicePLOS Pathogens, 2008
- Inhibition of the cytokine response does not protect against lethal H5N1 influenza infectionProceedings of the National Academy of Sciences, 2007
- Avian Influenza Virus (H5N1): a Threat to Human HealthClinical Microbiology Reviews, 2007
- Role of Host Cytokine Responses in the Pathogenesis of Avian H5N1 Influenza Viruses in MiceJournal of Virology, 2007
- A DNA transfection system for generation of influenza A virus from eight plasmidsProceedings of the National Academy of Sciences of the United States of America, 2000